To help clinicians and patients better identify the many medications available to treat HIV infection, NIAID recently published a poster titled "Drugs That Fight HIV." The poster features images of FDA-approved antiretroviral medications, grouped by drug class and clearly identified by both generic and trade names. Intended as a tool for health care professionals to use when discussing HIV treatment with patients, the poster is also available in brochure format in English and Spanish.

Please note that the new antiretroviral medications rilpivirine (Edurant) and the fixed-dose combination of emtricitabine/rilpivirine/tenofovir DF (Complera) were approved by the FDA subsequent to publication of these NIAID educational materials. Hence the poster does not include an image and accompanying information on Complera, and the brochures do not include images of Complera or rilpivirine.

AIDSinfo drug summaries have been updated with the images featured in the NIAID educational materials as well as images of the newly approved drugs rilpivirine and Complera. Visit the AIDSinfo drug database to view the images.